with treatment options available for older children and adults." The open-label WIL-33 trial enrolled and treated 12 patients, all under the age of 6 and diagnosed with severe VWD. Wilate® was administered two to three times per week at a...
Spectrum Science, an independent, full-service, strategic platform offering integrated clinical, commercial, and communications services, announced the appointment of Marie Emms as President of its clinical trial recruitment and retention...
Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. announce the development and validation of a DOT-like drug-test panel for breath testing. The validated laboratory method expands Omega's breath-testing capability beyond...
data evaluating VTAMA cream. The presentation includes a pooled post hoc analysis of data from the pivotal Phase 3 ADORING 1 and ADORING 2 clinical trials evaluating the efficacy and safety of VTAMA cream across age subgroups of pediatric and adult...
relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 EPCORE® FL-1 trial, which evaluated fixed-duration TEPKINLY in combination with R2 compared to standard of care R2. "Follicular...
autonomous medication management, announced that Nnamdi Njoku has been appointed President of the Company, effective July 1, 2026. Mr. Njoku will retain his role of Chief Operating Officer (COO), while Randall Lipps will continue to serve as Chief...
Starting today FDA-approved Wegovy® (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity. Obesity is a serious, common chronic disease among older Americans and Wegovy®...
to transform how prescriptions are dispensed, verified and delivered. The company recently closed an oversubscribed $12.6 million seed round led by AlleyCorp, following a $6 million pre-seed round led by Riot Ventures less than a year ago, bringing...
with severe, acute hypotension. Norepinephrine Bitartrate Injection, USP is available as a carton of ten 4 mg per 4 mL (1 mg per mL) single-dose vials. In line with Avenacy’s mission to champion patient safety and streamline patient care,...
maintaining familiar workflows with greater versatility by seamlessly switching between RF and PFA,” said Nicolas Derval1, M.D., Bordeaux, France. “This flexibility also provides greater ability to adjust treatment to different patient anatomies,...
StatLab Medical Products, a leading global developer and manufacturer of pathology supplies and equipment, announced the global launch of the CytoPath Disc, an innovative cell block preparation technology designed to standardize and simplify cell...
lowering fasting triglyceride levels by up to 72% compared to placebo at six months and sustaining those reductions at 12 months. Additionally, TRYNGOLZA significantly reduced acute pancreatitis events by up to 91%. Among patients treated with...
lowering fasting triglyceride levels by up to 72% compared to placebo at six months and sustaining those reductions at 12 months. Additionally, TRYNGOLZA significantly reduced acute pancreatitis events by up to 91%. Among patients treated with...
ZETA SURGICAL and HOPE Therapeutics, an NRx Pharmaceuticals company announced the first patient treatment with the FDA-cleared Zeta TMS Navigation System at a HOPE Therapeutics clinic in Sarasota. HOPE has installed Zeta TMS Navigation Systems at...
can visit: https://mykymbee.com/hcp. If you or your doctor have questions about KYMBEE™, reach out to Upsher-Smith at 1-888-650-3789. IMPORTANT SAFETY INFORMATION for KYMBEE™ (deflazacort) Who should not take KYMBEE? Do not take if you have had...
Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal...
Gandeeva Therapeutics, Inc., a biotech at the forefront of cryo-electron microscopy (cryo-EM)–driven drug design, and Zymeworks Inc. (Nasdaq: ZYME), a global biotechnology company, have partnered to visualize structures of antibody-antigen...
that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) to include children and adolescents aged 2 through 17 years who have completed a primary pediatric...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Bortezomib for Injection in the United States. The product contains the same active ingredient as VELCADE®, as approved by...
of the most prominent leaders in Italian and European biotech: founder of Gentium, a Nasdaq-listed company acquired in 2014 by Jazz Pharmaceuticals in a transaction worth approximately USD 1 billion, she is today President and co-founder of...
